Nonstandard abbreviations used: AMPK, AMP-activated protein kinase; MIF, macrophage migration inhibitory factor; LAD, left anterior descending; KD, kinase dead; PS, peak shortening; ±dL/dt, maximal velocity of shortening/re-lengthening; TR90, time-to-90% re-lengthening; TPS, time-to-peak shortening; INF, infarct size; AAR, area at risk; TTC, 2,3,5-triphenyltetrazolium chloride.
INTRODUCTION
The most common cause of damage to the myocardium is ischemic injury caused by complete or partial occlusion of the coronary arteries 1 . Numerous investigators have observed a decreased ability of the aged myocardium to tolerate an ischemic or hypoxic stress in both animal models and in human subjects [2] [3] [4] . In addition, aging has been shown to decrease myocardial tolerance to specific components of ischemic injury, including oxidative stress 5 . It is widely accepted that aging is accompanied by a general decline in stress resistance 6 . Multiple clinical trials have demonstrated that the mortality after myocardial infarction, coronary angioplasty, and cardiac surgery in patients 70 years or older is significantly higher than that of younger age groups 7, 8 .
Although several clinical factors contribute to the poor prognosis of elderly patients with ischemic heart disease 9,10 , there is evidence in experimental animal [11] [12] [13] and humans 4,14 to suggest that this may be related to a decline in intrinsic myocardial resistance to injury. However, the mechanisms responsible for ischemic intolerance are incompletely understood and the activities of signaling pathways important in regulating cellular responses to ischemia/reperfusion remain largely unknown.
In the heart, the AMP-activated protein kinase (AMPK) signaling pathway is activated by a variety of cellular stresses such as glucose deprivation, ischemia, hypoxia, oxidative stress, and hyperosmotic stress 15 . AMPK affects energy intake, utilization, and storage by regulation of food intake, substrate flux and metabolism 16 . AMPK regulates many pathways in the heart that control glucose and lipid uptake, storage, and utilization 15, 16 , and it modulates the activity of metabolic enzymes, ion channels, gene expression. AMPK also functions by interacting with other intracellular signaling pathways 15 . The activity of AMPK or its yeast homologue, Snf1, may be altered with age 17, 18 . Moreover, genetic mutations in the AMPK genes cause metabolic dysfunction of cardiac and skeletal muscles, suggesting that alterations in AMPK have clinical consequences and may potentially contribute to the decline in stress tolerance observed with aging 19, 20 . Intriguingly, our earlier studies have demonstrated that AMPK regulates myocardial metabolism during low-flow ischemia/reperfusion and limits ischemic injury and apoptosis during post-ischemic reperfusion 21 . Specifically, the loss of AMPK function results in impaired glucose uptake and glycolysis, poor recovery of post-ischemic function, and increased myocyte necrosis and apoptosis 21 . However, whether AMPK activity is reduced in aged heart and whether such a reduction contributes to increased ischemia injury in aged hearts have not been elucidated.
We recently reported that macrophage migration inhibitory factor (MIF), an innate cytokine that controls the inflammatory 'set point' by regulating the release of other proinflammatory cytokines 22 , modulates the activation of AMPK during ischemia, functionally linking inflammation and metabolism in the heart 23 . We anticipate that genetic variation in the expression of MIF, which is encoded in a functionally polymorphic locus 24 , may impact the responsiveness of the human heart to ischemia via the AMPK pathway, and that diagnostic MIF genotyping might predict risk in patients with coronary artery disease 23 . Accordingly, it is important to delineate the effect of aging on the MIF-AMPK adaptive signaling pathway in response to ischemic stress. In the present study, we show that aging leads to impaired cardiac AMPK activation during ischemia, which is associated with intolerance to ischemic stress in aged hearts.
RESULTS

Impaired Ischemic Activation of AMPK in Aged Heart
To investigate the impact of aging on heart AMPK signaling response to ischemia stress, we compared the AMPK signaling response in hearts from young (4-6 months, n=6) and aged (24-26 months, n=6) mice (male C57BL/6 strain) during in vivo regional ischemia. We observed that phosphorylation of AMPK at Thr 172 of catalytic α subunit ( Figure 1A ) and the activity of AMPKα1 and α2 was decreased in aged hearts compared with their younger counterparts ( Figure 1 ). Similar effects also were observed with the isolated-perfused hearts. Low-flow (20 min) global ischemia stimulated AMPK phosphorylation and activation without affecting AMPK protein abundance in both young hearts and aged hearts ( Figure 2 ). However, the activation of AMPK was markedly stronger in young hearts than aged hearts. Taken together, these results suggest that the AMPK responsiveness to ischemia is reduced in the aged heart.
Coronary Flow in Aged Hearts
Both young and aged hearts were subject to a constant left atrial preload of 15 cm H 2 O and an aortic afterload of 80 H 2 O for 20 minutes, followed by 20 minutes of low flow ischemia (reducing afterload and coronary perfusion pressure to 30 cm H 2 O). As shown in Figure 3 , heart rates were similar in aged and young hearts during both control and ischemia. There was no significant difference in coronary flow at control and ischemic conditions between the two age groups. These data indicate that the ischemic stimulus is comparable in young and aged hearts during low flow ischemia in the working heart model.
Aged Hearts Demonstrated Intolerance to Ischemic Injury
Mounting evidence supports a beneficial effect of AMPK in limiting cardiac damage during ischemia/reperfusion 21, 25, 26 . To determine the consequences of the blunted ischemic AMPK activation during aging, myocardial infarct size in response to in vivo regional ischemia/reperfusion was compared between young and aged hearts. After 20 minutes of coronary artery ligation and 4 hours of reperfusion, the myocardial infarct size induced by in vivo regional ischemia/reperfusion in aged hearts was significantly larger than that in young hearts ( Figure 4 ). To confirm if the blunted ischemic AMPK activation is a factor associated with intolerance to ischemic injury during aging, we compared the response to ischemic stress of young AMPK-kinase dead (KD) transgenic mouse hearts and the WT littermates. Notably, the myocardial infarct size was significantly greater in AMPK KD hearts than that in WT littermates hearts ( Figure 4 ). However, there was significant difference in infarct size between the aged WT and young AMPK-KD hearts ( Figure 4 ). Together, these data suggest that impaired AMPK activation in aged hearts in response to ischemia might result in the increased infarct size during ischemia/reperfusion.
Down-regulation of MIF Expression in Aged Heart
We recently reported that endogenous MIF modulates the activation of cardiac AMPK, which plays an important role in mitigating cardiac damage caused by ischemia/reperfusion 23 . To determine whether the blunted ischemic AMPK activation was due to MIF deficiency in the aged hearts, we examined the expression levels of MIF in both young and aged hearts. The results demonstrated that both mRNA and protein expression of cardiac MIF were markedly decreased in the aged hearts compared with young hearts ( Figure 5 ), supporting our hypothesis of an agingassociated reduction of MIF, an up-stream factor in ischemic AMPK activation, in the hearts.
This observation also is in line with the previous observation that MIF KO hearts display reduced tolerance to ischemic stress compared with WT mouse hearts 23 .
Impaired AMPK Activation of MIF KO Hearts/Cardiomyocytes in Response to
Ischemia/Hypoxia
To verify the permissive role of MIF as a mediator of ischemic AMPK activation, in vivo regional ischemia was performed by occlusion of the left anterior descending artery (LAD) in both MIF KO and WT mice. The results clearly showed that AMPK activation was markedly reduced in MIF KO hearts compared with WT hearts in response to in vivo regional ischemia ( Figure 6A ). Moreover, the ischemic activation of AMPK was reduced in the MIF receptor, CD74 deficient heart as well ( Figure 6A ). We next measured the response of isolated cardiomyocytes from both MIF KO and WT hearts to hypoxia treatment; the data showed that hypoxia stimulated AMPK phosphorylation of cardiomyocytes in a time-dependent manner and that the hypoxic AMPK activation of MIF KO cardiomyocytes was significantly impaired when compared to WT cardiomyocytes ( Figure 6B ). MIF KO mice nevertheless demonstrated a normal baseline cardiac phenotype with respect to left ventricular size and function, histology, and the expression of AMPK and glucose transporter proteins 23 .
MIF Dampened Hypoxia-induced Contractile Dysfunction of Cardiomyocytes in Aged Hearts
We also compared the response to hypoxia of cardiomyocytes from aged hearts with that from young hearts ( Figure 7 ). Hypoxia treatment resulted in dysfunction of contractility in both young and aged cardiomyocytes, i.e. depressed peak shortening (PS), maximal velocity of shortening/relengthening (±dL/dt), and prolonged time-to-90% re-lengthening (TR 90 ).
Nonetheless, the extent of hypoxic dysfunction was significantly accentuated in aged cardiomyocytes compared with young cardiomyocytes. To determine whether relative MIF deficiency in the aged hearts ( 
DISCUSSION
Myocardial infarction is a major threat of morbidity and mortality in the elderly, and alterations in the heart that occur during aging result in decreased myocardial function and render it more susceptible to damage 27, 28 . A common cause of damage to the myocardium is ischemic injury, and aging is known to be associated with an increase in myocardial susceptibility to ischemia and a decrease in post-ischemic recovery of cardiac function 29 . Elucidation of the mechanisms of aging in the heart thus may serve to improve the overall quality of cardiovascular health in this ever increasing patient population.
In this study, we demonstrate for the first time that the expression of endogenous cardiac MIF, an up-stream activator of AMPK 23 , is reduced in the aged hearts. Moreover, ischemiainduced AMPK activation was significantly blunted in the aged hearts, which may lead to greater myocardial injury in the aged versus young hearts. Given mounting evidence that AMPK plays an important role in cardioprotection against myocardial ischemia 21, 25, 26 , these observations provide strong evidence that cardiac MIF down-regulation and impaired ischemic AMPK activation may play a causative role in the intolerance of the aged heart to ischemic injury.
We have focused previous research on the hypothesis that aging is accompanied by a reduced ability to activate adaptive responses to stress, and that this in turn contributes to the onset of age-related diseases and functional deficits that occur with normal aging. Experiments in primary cultured hepatocytes derived from mice and rats of different ages support this view 30, 31 . We demonstrated that aging is associated with a diminished ability to activate pro-survival signaling pathways following oxidant exposure, which is usually correlated with reduced survival 30 . In the heart, ATP depletion and the subsequent accumulation of AMP that results from ischemia activates AMPK, which is a central component of the cellular stress response that shifts metabolism toward ATP restoration 32, 33 . Dually activated by AMP and by phosphorylation, AMPK promotes fatty acid oxidation and glucose uptake, while it inhibits anabolic processes such as fatty acid and protein synthesis 34 . The activity of AMPK or its yeast homologue, Snf1, may be altered with age 17, 18 . Moreover, genetic mutations in AMPK cause metabolic dysfunction of cardiac and skeletal muscles, suggesting that alterations in AMPK have clinical consequences and may potentially contribute to the decline in stress tolerance observed with aging 19 . Specifically, the loss of AMPK function results in impaired glucose uptake and glycolysis, poor recovery of post-ischemic function, and increased myocyte necrosis and apoptosis 21 . Thus, AMPK is critical in mediating the metabolic and functional responses of the heart to ischemia and reperfusion 21 . Our results demonstrate that aging-associated reductions in ischemic AMPK activation may be an important contributing factor in the increased susceptibility of cardiomyocytes to ischemic injury.
Recent studies have demonstrated that in addition to its pleiotropic role in inflammatory diseases 35 , MIF also regulates metabolic responses 36, 37 . In systemic inflammatory diseases, high levels of MIF are considered to be deleterious. However, we recently identified a novel mechanism for MIF action via AMPK activation that establishes an important link between pathways central to inflammation and metabolism. MIF release leads to the autocrine/paracrine activation of the AMPK signaling pathway in the ischemic heart 23 . The present study demonstrated that aging is associated with a down-regulation of cardiac MIF expression, which may lead to intolerance to ischemic stress due to reduced AMPK activation. Furthermore, exogenous MIF restores ischemic AMPK activation in the aged cardiomyocytes and mitigates the contractile dysfunction of aged cardiomyocytes caused by hypoxia.
We conclude that an aging-associated reduction in MIF in the heart leads to a blunted, ischemic AMPK activation response that is an important contributing factor in the reduced tolerance to ischemia insult in aged individuals. Pharmacologic interventions that restore MIF signaling and AMPK activity in the aged heart may be a novel means to limit cardiac damage caused by ischemia/reperfusion in older patients. 23 .
MATERIALS AND METHODS
Experimental
The core temperature was maintained at 37°C with a heating pad. After left lateral thoracotomy, the left anterior descending artery (LAD) was occluded for 20 min with an 8-0 nylon suture and polyethylene tubing to prevent arterial injury, and then reperfused for 4 h. Electrocardiograms confirmed ischemic repolarization changes (ST-segment elevation) during coronary occlusion (AD Instruments). The hearts then were excised and perfusion stained to delineate the extent of myocardial necrosis as a percent of non-perfused ischaemic area at risk (AAR). Viable tissue in the ischemic region was stained red by 2,3,5-triphenyltetrazolium (TTC) and the non-ischaemic region was stained blue with Evan's blue dye. Hearts were fixed and sectioned into 1-mm slices, photographed using a Leica microscope and analyzed using NIH Image software.
Activity of AMPK in Young and Aged Hearts.
Isoform-specific (α1 and α2) AMPK activity was determined using a previously described immune complex kinase assay 41 . AMPK was immunopurified from heart lysates with protein G/A Sepharose coupled to α subunit isoform-13 specific antibodies. The immunocomplexes were washed extensively and AMPK activity was determined with the SAMS peptide (HMRSAMSGLHLVKRR).
Working Heart Perfusion and Measurement of Cardiac Function. Mice were deeply anesthetized with sodium pentobarbital (5-10 mg i.p.) and hearts were excised and placed in an ex vivo working heart system 42 . Heart rate and ventricular pressure were recorded with a pressure transducer in the aortic outflow line (Harvard Apparatus) 43 . Data were collected with the Chart5 system from AD Instruments. Cardiac output and aortic flows were obtained by measuring the flow into the left atria and from the afterload line with the Transonic flow probes.
Coronary flow was calculated from the difference of the cardiac output and aortic flows.
Immunoblotting. Immunoblots were performed as previously described 44 . Heart homogenates were resolved by SDS-PAGE and transferred onto polyvinylidene difluoride membranes. For reprobing, membranes were stripped with 50 mmol/L Tris-HCl, 2% SDS, and 0.1 mol/L β-mercaptoethanol (pH 6.8). Rabbit polyclonal antibodies against phosphor-AMPK and total AMPK were purchased from Cell Signaling. Rabbit polyclonal antibodies against MIF and β-tubulin were from Santa Cruz.
mRNA Analysis by Real-time PCR. Heart RNA was isolated using TRIzol ® regent (Invitrogen) and RNAeasy (Qiagen). cDNA was synthesized using the ThermoScript TM RT-PCR system (Invitrogen) at a concentration of 100 ng RNA/µl cDNA. The iCycler Q-PCR machine and SYBR Green Supermix from Bio-Rad were used 45 . All reactions had a correlation coefficient of ≥0.98, efficiency in the 90-110% range, and were performed in duplicate. For each target gene, a standard curve was constructed and the starting quantity (SQ) of mRNA was calculated using the Bio-Rad iCycler iQ Real-Time PCR Detection System Software. Results for each sample were normalized by dividing the SQ of the target gene by the SQ of β-actin for that same sample. The specific amplification of the desired target gene was verified by the correlation coefficient of the standard curve of ≥ 0.98, the appearance of a single peak in the melting curve at the predicted temperature, and the appearance of a single band of the predicted length upon gel electrophoresis. Table 1 shows the specific primers and reaction conditions. The primers were designed using the Beacon Designer Software from Bio-Rad. The reactions employed SYBR Green Supermix and the conditions were: 1 cycle of 95ºC for 3 min; 40 cycles of 95ºC for 15 sec followed by 60ºC for 1 min.
Isolation of Mouse Cardiomyocytes and Measurement of Cardiomyocyte Contractile
Function. Cardiomyocytes were enzymatically isolated as described previously 46, 47 . The mechanical properties of cardiomyocytes were assessed using a SoftEdge MyoCam system (IonOptix Corporation, Milton, MA) 47 . IonOptix SoftEdge software was used to capture changes in cell length during shortening and re-lengthening. Cell shortening and re-lengthening were assessed using the following indices: peak shortening (PS), the amplitude myocytes shortened on electrical stimulation, which is indicative of peak ventricular contractility; time-to-PS (TPS), the duration of myocyte shortening, which is indicative of systolic duration; time-to-90% relengthening (TR90); the duration to reach 90% re-lengthening, which is indicative of diastolic duration (90% rather 100% re-lengthening was used to avoid noisy signal at baseline concentration); and maximal velocities of shortening/re-lengthening, maximal slope (derivative) of shortening and re-lengthening phases, which is indicative of maximal velocities of ventricular pressure increase/decrease. Native sequence, mouse MIF was produced recombinantly as described previously 48 .
Statistical Analysis. Data were means ± SEM. Significance was tested by Student 2-tail t tests or 2-way repeated measures ANOVA with Bonferroni correction for multiple comparisons when appropriate. 
